Clinical Trial Update: Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating utidelone plus bevacizumab for advanced breast cancer with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Utidelone (utidelone)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN